Skip to main content
Erschienen in: Journal of Cancer Education 6/2018

01.07.2017

What is the Role of the Oncology Nurse in Fertility Preservation Counseling and Education for Young Patients?

verfasst von: Jessica Keim-Malpass, Hannah S. Fitzhugh, Laura P. Smith, Ryan P. Smith, Jeanne Erickson, Mike G. Douvas, Tanya Thomas, Gina Petroni, Linda Duska

Erschienen in: Journal of Cancer Education | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Oncology nurses are uniquely positioned to offer fertility preservation counseling and education for cancer patients of reproductive age, yet there is a dearth of research that focuses on current practice and perceptions of nursing role. In 2013, the American Society of Clinical Oncology extended the duties of fertility preservation counseling among patients of reproductive age undergoing cancer treatment to include registered nurses and other allied health professionals as active partners in the counseling and education process. This study used a cross-sectional descriptive survey to assess current practices, role perceptions, and barriers to fertility preservation counseling among registered nurses working in an academic care setting with outpatient and inpatient services. There were significant gaps in current practices and perceptions of roles regarding fertility preservation counseling. Many nurses expressed the perception that fertility preservation counseling was important, but it was outside the scope of their practice to perform this education. This preliminary work defined need for an interdisciplinary fertility preservation team, communication surrounding educational practice norms, and designated oncofertility navigator.
Literatur
1.
Zurück zum Zitat National Cancer Institute (2016) SEER stat fact sheets: cancer of any site. Natl. Cancer Inst. National Cancer Institute (2016) SEER stat fact sheets: cancer of any site. Natl. Cancer Inst.
2.
Zurück zum Zitat Bleyer A, Barr R (2009) Cancer in young adults 20 to 39 years of age: overview. Semin Oncol 36:194–206CrossRefPubMed Bleyer A, Barr R (2009) Cancer in young adults 20 to 39 years of age: overview. Semin Oncol 36:194–206CrossRefPubMed
3.
Zurück zum Zitat Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500–2510CrossRefPubMedPubMedCentral Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500–2510CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Fallat ME, Hutter J (2008) Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics 121:e1461–e1469CrossRefPubMed Fallat ME, Hutter J (2008) Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics 121:e1461–e1469CrossRefPubMed
5.
Zurück zum Zitat American Society of Reproductive Medicine (2013) Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril Am Soc Reprod Med 100:1224–1231CrossRef American Society of Reproductive Medicine (2013) Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril Am Soc Reprod Med 100:1224–1231CrossRef
7.
Zurück zum Zitat Goossens J, Delbaere I, Van Lancker A, Beeckman D, Verhaeghe S, Van Hecke A (2014) Cancer patients’ and professional caregivers’ needs, preferences and factors associated with receiving and providing fertility-related information: a mixed-methods systematic review. Int J Nurs Stud 51:300–319CrossRefPubMed Goossens J, Delbaere I, Van Lancker A, Beeckman D, Verhaeghe S, Van Hecke A (2014) Cancer patients’ and professional caregivers’ needs, preferences and factors associated with receiving and providing fertility-related information: a mixed-methods systematic review. Int J Nurs Stud 51:300–319CrossRefPubMed
8.
Zurück zum Zitat Barlevy D, Wangmo T, Elger BS, Ravitsky V (2016) Attitudes, beliefs, and trends regarding adolescent oncofertility discussions: a systematic literature review. J Adolesc Young Adult Oncol. X Barlevy D, Wangmo T, Elger BS, Ravitsky V (2016) Attitudes, beliefs, and trends regarding adolescent oncofertility discussions: a systematic literature review. J Adolesc Young Adult Oncol. X
9.
Zurück zum Zitat Kelvin JF, Thom B, Benedict C, Carter J, Corcoran S, Dickler MN et al (2016) Cancer and fertility program improves patient satisfaction with information received. J Clin Oncol 34:12–18CrossRef Kelvin JF, Thom B, Benedict C, Carter J, Corcoran S, Dickler MN et al (2016) Cancer and fertility program improves patient satisfaction with information received. J Clin Oncol 34:12–18CrossRef
10.
Zurück zum Zitat Taylor JF, Ott M (2014) Fertility preservation after a childhood cancer diagnosis: a systematic review of adolescents’ and young adults’, parents’, and providers’ knowledge, beliefs, and attitudes. J Adolesc Health 54:S48–S49CrossRef Taylor JF, Ott M (2014) Fertility preservation after a childhood cancer diagnosis: a systematic review of adolescents’ and young adults’, parents’, and providers’ knowledge, beliefs, and attitudes. J Adolesc Health 54:S48–S49CrossRef
11.
Zurück zum Zitat Murray AN, Chrisler JC, Robbins ML (2015) Oncology nurses report attitudes and barriers to discussing fertility preservation. 20:93–99 Murray AN, Chrisler JC, Robbins ML (2015) Oncology nurses report attitudes and barriers to discussing fertility preservation. 20:93–99
12.
Zurück zum Zitat Vadaparampil ST, Gwede CK, Meade C, Kelvin J, Reich RR, Reinecke J et al (2016) ENRICH: a promising oncology nurse training program to implement ASCO clinical practice guidelines on fertility for AYA cancer patients. Patient Educ Couns 99:1907–1910CrossRefPubMedPubMedCentral Vadaparampil ST, Gwede CK, Meade C, Kelvin J, Reich RR, Reinecke J et al (2016) ENRICH: a promising oncology nurse training program to implement ASCO clinical practice guidelines on fertility for AYA cancer patients. Patient Educ Couns 99:1907–1910CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Hsieh H-F, Shannon SE (2005 [cited 2014 Jan 20]) Three approaches to qualitative content analysis. Qual Health Res 15:1277–1288CrossRefPubMed Hsieh H-F, Shannon SE (2005 [cited 2014 Jan 20]) Three approaches to qualitative content analysis. Qual Health Res 15:1277–1288CrossRefPubMed
14.
Zurück zum Zitat Quinn GP, Woodruff TK, Knapp CA, Bowman ML, Reinecke J, Vadaparampil ST (2016) Expanding the oncofertility workforce: training allied health professionals to improve health outcomes for adolescents and young adults. J Adolesc Young Adult Oncol 5:292–296CrossRefPubMedPubMedCentral Quinn GP, Woodruff TK, Knapp CA, Bowman ML, Reinecke J, Vadaparampil ST (2016) Expanding the oncofertility workforce: training allied health professionals to improve health outcomes for adolescents and young adults. J Adolesc Young Adult Oncol 5:292–296CrossRefPubMedPubMedCentral
15.
Metadaten
Titel
What is the Role of the Oncology Nurse in Fertility Preservation Counseling and Education for Young Patients?
verfasst von
Jessica Keim-Malpass
Hannah S. Fitzhugh
Laura P. Smith
Ryan P. Smith
Jeanne Erickson
Mike G. Douvas
Tanya Thomas
Gina Petroni
Linda Duska
Publikationsdatum
01.07.2017
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 6/2018
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1247-y

Weitere Artikel der Ausgabe 6/2018

Journal of Cancer Education 6/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.